4//SEC Filing
KROIN DAVID 4
Accession 0000950170-24-058720
CIK 0000906709other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:36 PM ET
Size
9.5 KB
Accession
0000950170-24-058720
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2024-05-10$1.78/sh−56,000$99,630→ 18,344,000 total(indirect: See Footnote)
KROIN DAVID
10% Owner
Transactions
- Sale
Common Stock
2024-05-10$1.78/sh−56,000$99,630→ 18,344,000 total(indirect: See Footnote)
Deep Track Capital, LP
10% Owner
Transactions
- Sale
Common Stock
2024-05-10$1.78/sh−56,000$99,630→ 18,344,000 total(indirect: See Footnote)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.745 to $1.81, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
- [F2]Represents securities held by Deep Track Biotechnology Master Fund, Ltd. Deep Track Capital, LP. is the investment manager of Deep Track Biotechnology Master Fund, Ltd. Mr. David Kroin is the managing member of Deep Track Capital GP, LLC, the general partner of Deep Track Capital, LP., and by virtue of such status may be deemed to be the beneficial owner of the shares owned by Deep Track Biotechnology Master Fund, Ltd. Deep Track Capital, L.P. and Mr. Kroin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001397513
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:36 PM ET
- Size
- 9.5 KB